Abstract:Oryzanol is a class of nonsaponifiable lipids of rice bran oil (RBO). More specifically, oryzanol is a group of ferulic acid esters of triterpene alcohol and plant sterols. In experiment 1, the mechanisms of the cholesterol-lowering action of oryzanol were investigated in 32 hamsters made hypercholesterolemic by feeding chow-based diets containing 5% coconut oil and 0.1% cholesterol with or without 1% oryzanol for 7 wk. Relative to the control animals, oryzanol treatment resulted in a significant reduction in plasma total cholesterol (TC) (28%, P < 0.01) and the sum of IDL-C, LDL-C, and VLDL-C (NON-HDL-C) (34%, P < 0.01). In addition, the oryzanol-treated animals also exhibited a 25% reduction in percent cholesterol absorption vs. control animals. Endogenous cholesterol synthesis, as measured by the liver and intestinal HMG-CoA reductase activities, showed no difference between the two groups. To determine whether a lower dose of oryzanol was also efficacious and to measure aortic fatty streaks, 19 hamsters in experiment 2 were divided into two groups and fed for 10 wk chow-based diets containing 0.05% cholesterol and 10% coconut oil (w/w) (control) and the control diet plus 0.5% oryzanol (oryzanol). Relative to the control, oryzanol-treated hamsters had reduced plasma TC (44%, P < 0.001), NON-HDL-C (57%, P < 0.01), and triglyceride (TG) (46%, P < 0.05) concentrations. Despite a 12% decrease in high density lipoprotein cholesterol (HDL-C) (P < 0.01), the oryzanol-treated animals maintained a more optimum NON-HDL-C/HDL-C profile (1.1 +/- 0.4) than the control (2.5 +/- 1.4; P < 0.0075). Aortic fatty streak formation, so defined by the degree of accumulation of Oil Red O-stained macrophage-derived foam cells, was reduced 67% (P < 0.01) in the oryzanol-treated animals. From these studies, it is concluded that a constituent of the non-saponifiable lipids of RBO, oryzanol, is at least partially responsible for the cholesterol-lowering action of RBO. In addition, the cholesterol-lowering action of oryzanol was associated with significant reductions in aortic fatty streak formation.

Oryzanol Modifies High Fat Diet-Induced Obesity, Liver Gene Expression Profile, and Inflammation Response in Mice.

Oryzanol Attenuates High Fat and Cholesterol Diet-Induced Hyperlipidemia by Regulating the Gut Microbiome and Amino Acid Metabolism.

Oryzanol Alleviates High Fat and Cholesterol Diet-Induced Hypercholesterolemia Associated with the Modulation of the Gut Microbiota in Hamsters

Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters

Effects of Ferulic Acid and Γ-Oryzanol on High-Fat and High-Fructose Diet-Induced Metabolic Syndrome in Rats.

Octacosanol Modifies Obesity, Expression Profile and Inflammation Response of Hepatic Tissues in High-Fat Diet Mice

The Function of Oat - Rice in Reducing Obesity and Blood Lipids of Obese Mice

Oroxylin A Prevents Alcohol-Induced Hepatic Steatosis Through Inhibition of Hypoxia Inducible Factor 1Alpha.

Proteomic study of gamma-oryzanol preventive effect on a diet-induced non-alcoholic fatty liver disease model

Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner

Effect of Γ-Oryzanol on the Expression of Lipopolysaccharide-Induced Inflammatory Factors in Macrophages

Oleanolic Acid Attenuates Obesity Through Modulating the Lipid Metabolism in High-Fat Diet-Fed Mice

Osthole Improves Fat Milk-Induced Fatty Liver in Rats: Modulation of Hepatic PPAR-alpha/gamma-mediated Lipogenic Gene Expression.

Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB

Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage Via Targeting the Gut Microbiota Accompanied by the TLR4/NF-κB/NLRP3 Cascade Response in Vivo.

Oroxylin A Suppresses the Development and Growth of Colorectal Cancer Through Reprogram of HIF1α-modulated Fatty Acid Metabolism.

Study on Possible Mechanism of Orotic Acid–induced Fatty Liver in Rats

Dietary Fiber Prevents Obesity-Related Liver Lipotoxicity by Modulating Sterol-Regulatory Element Binding Protein Pathway in C57BL/6J Mice Fed a High-Fat/cholesterol Diet

Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARα.

Oat Β-Glucan Inhibits Adipogenesis and Hepatic Steatosis in High Fat Diet-Induced Hyperlipidemic Mice Via AMPK Signaling

Differential Responses Of Hepatic Endoplasmic Reticulum Stress And Inflammation In Diet-Induced Obese Rats With High-Fat Diet Rich In Lard Oil Or Soybean Oil